Development and Validation of a Multimodal Artificial Intelligence Model for Early Prediction of Acute Myocardial Infarction
Starting soon
Conditions studied: Myocardial Infarction
In brief
Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome these limitations, the present investigation aims to develop a post-AMI prognostic model that integrates comprehensive multimodal data.
Key facts
- Study ID
- NCT07457320
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- People needed
- 1500
- Starts
- 2026-04-01
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2026-03-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years old
- Presented with myocardial infarction, including NSTEMI and STEMI
- Undergoing successful percutaneous coronary intervention.
You may not qualify if…
- Poor imaging quality or a data missing rate >30%
Where it is running
- The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009 — Hangzhou, Zhejiang, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.